Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration

By Harro Janette M.   Peters Brian M.   O'May Graeme A.   Archer Nathan   Kerns Patrick   Prabhakara Ranjani   Shirtliff Mark E.  

FEMS Immunology & Medical Microbiology, Vol. 59, Iss. 3, 2010-08 ,pp. : 306-323

Blackwell Publishing

Access to resources Recommend Favorite

Oxidative and nitrosative stress in Staphylococcus aureus biofilm

By Arce Miranda Julio E.   Sotomayor Claudia E.   Albesa Inés   Paraje María G.  

FEMS Microbiology Letters, Vol. 315, Iss. 1, 2011-02 ,pp. : 23-29

Blackwell Publishing

Access to resources Recommend Favorite

Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models

By Smith K.   Gemmell C.   Lang S.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 32, Iss. 10, 2013-10 ,pp. : 1327-1332

Springer Publishing Company

Access to resources Recommend Favorite

Outcome for invasive Staphylococcus aureus infections

By Jacobsson G.   Gustafsson E.   Andersson R.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Iss. 9, 2008-09 ,pp. : 839-848

Springer Publishing Company

Access to resources Recommend Favorite

Flucloxacillin treatment of Staphylococcus aureus meningitis

By Ritchie S.   Rupali P.   Roberts S.   Thomas M.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 7, 2007-07 ,pp. : 501-504

Springer Publishing Company

Access to resources Recommend Favorite